Misoprostol for the prevention and treatment of postpartum hemorrhage (Q37974701)

26 August 2017

Misoprostol for the prevention and treatment of postpartum hemorrhage (English)

1 reference

26 August 2017

0 references

1 reference

4

Beverly Winikoff

1 reference

26 August 2017

Wendy R Sheldon

1

1 reference

26 August 2017

Jennifer Blum

series ordinal

2

1 reference

26 August 2017

Jill Durocher

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

11 January 2012

1 reference

Expert Opinion on Investigational Drugs

26 August 2017

1 reference

26 August 2017

21

1 reference

26 August 2017

2

1 reference

26 August 2017

235-250

1 reference

WHO analysis of causes of maternal death: a systematic review

26 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Postpartum hemorrhage. A 90s approach to an age-old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

WHO multicentre randomised trial of misoprostol in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Prevention of postpartum hemorrhage with misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Joint statement: management of the third stage of labour to prevent post-partum haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Oral misoprostol versus injectable methylergometrine in management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol versus oxytocin for the reduction of postpartum blood loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Oral misoprostol in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol versus oxytocin in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Sublingual misoprostol versus methylergometrine for active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol for prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

The use of rectal misoprostol as active pharmacological management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

What measured blood loss tells us about postpartum bleeding: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol for the prevention and treatment of postpartum haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Oral misoprostol for third stage of labor: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Pharmacokinetics of different routes of administration of misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

High fever following postpartum administration of sublingual misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Severe hyperthermia following oral misoprostol in the immediate postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

Misoprostol to treat postpartum haemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.647405

10.1517/13543784.2012.647405

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference